Page last updated: 2024-11-05

dithiol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dithiol: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10334
SCHEMBL ID331198
MeSH IDM0046060

Synonyms (41)

Synonym
o-toluensulfamid
unii-u89b11p7sc
4-06-00-05890 (beilstein handbook reference)
u89b11p7sc ,
nsc-5391
4-methyl-1,2-benzenedithiol
toluene-3,4-dithiol
3,4-dimercaptotoluol
nsc5391
3,4-dimercaptotoluene
496-74-2
1,2-benzenedithiol, 4-methyl-
toluene-3,4-dithiol, technical grade, 90%
4-methylbenzene-1,2-dithiol
TLD ,
4-methyl-1,2-dimercaptobenzene
usaf b-59
brn 1635270
o-toluenesulfonylamide
nsc 5391
o-toluensulfamid [czech]
dithiol
1,2-dimercapto-4-methylbenzene
einecs 207-828-3
2Z94
T0266
1-toluene-3,4-dithiol
3,4-dithiotoluene
3,4-toluenedithiol ,
toluene-3,4-dithiol [mi]
SCHEMBL331198
4-methyl-o-benzenedithiol
DTXSID7060093
AKOS024386645
mfcd00004844
toluene-3,4-dithiol, for spectrophotometric det. of mo, sn, w, and also ag and re, >=97.0%
Q1111083
FT-0709480
bdbm512664
acs.jmedchem.1c00409_st.258
AS-57163

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Both ninhydrin and uramil could not redox cycle with glutathione (GSH) and were not selectively toxic to beta cells; their structure does not allow selective cellular uptake via the GLUT2 glucose transporter."( Relation between triketone structure, generation of reactive oxygen species, and selective toxicity of the diabetogenic agent alloxan.
Elsner, M; Gurgul-Convey, E; Lenzen, S, 2008
)
0.35

Bioavailability

ExcerptReferenceRelevance
" To aid in determining the bioavailability of CS2 from the administered dithiocarbamates, the urinary CS2 metabolites, 2-thiothiazolidine-4-carboxylic acid (TTCA) and 2-thiothiazolidin-4-ylcarbonylglycine (TTCG), were also determined."( Characterizing the influence of structure and route of exposure on the disposition of dithiocarbamates using toluene-3,4-dithiol analysis of blood and urinary carbon disulfide metabolites.
Amarnath, K; Amarnath, V; Johnson, DJ; Valentine, H; Valentine, WM, 2003
)
0.53

Dosage Studied

ExcerptRelevanceReference
" The input data are included adsorbent dosage (g), contact time (min) and pollutant concentration (mg/l)."( Adaptive neuro-fuzzy inference system model for adsorption of 1,3,4-thiadiazole-2,5-dithiol onto gold nanoparticales-activated carbon.
Ghaedi, AM; Ghaedi, M; Hosaininia, R; Taghizadeh, F; Vafaei, A, 2014
)
0.63
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (4)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Replicase polyprotein 1abSevere acute respiratory syndrome-related coronavirusKi1.40000.70001.05001.4000AID977610
Chain A, 3C-like proteinaseSevere acute respiratory syndrome-related coronavirusKi1.40000.70001.05001.4000AID977610
Replicase polyprotein 1abSevere acute respiratory syndrome-related coronavirusKi1.40000.00753.00839.1100AID1805801
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2Ki1.40000.00001.63079.0000AID1805801
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (1)

Processvia Protein(s)Taxonomy
symbiont-mediated perturbation of host ubiquitin-like protein modificationReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (12)

Processvia Protein(s)Taxonomy
3'-5'-RNA exonuclease activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
RNA-dependent RNA polymerase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
cysteine-type endopeptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
mRNA 5'-cap (guanine-N7-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
mRNA (nucleoside-2'-O-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
5'-3' RNA helicase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
K63-linked deubiquitinase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
K48-linked deubiquitinase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
3'-5'-RNA exonuclease activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
RNA-dependent RNA polymerase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
cysteine-type endopeptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA 5'-cap (guanine-N7-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA (nucleoside-2'-O-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA guanylyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
RNA endonuclease activity, producing 3'-phosphomonoestersReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
ISG15-specific peptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
5'-3' RNA helicase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
protein guanylyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
double membrane vesicle viral factory outer membraneReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
double membrane vesicle viral factory outer membraneReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2007FEBS letters, Nov-27, Volume: 581, Issue:28
Structural basis of mercury- and zinc-conjugated complexes as SARS-CoV 3C-like protease inhibitors.
AID1811Experimentally measured binding affinity data derived from PDB2007FEBS letters, Nov-27, Volume: 581, Issue:28
Structural basis of mercury- and zinc-conjugated complexes as SARS-CoV 3C-like protease inhibitors.
AID1805801Various Assay from Article 10.1021/acs.jmedchem.1c00409: \\Perspectives on SARS-CoV-2 Main Protease Inhibitors.\\2021Journal of medicinal chemistry, 12-09, Volume: 64, Issue:23
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (205)

TimeframeStudies, This Drug (%)All Drugs %
pre-199034 (16.59)18.7374
1990's15 (7.32)18.2507
2000's62 (30.24)29.6817
2010's67 (32.68)24.3611
2020's27 (13.17)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 57.72

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index57.72 (24.57)
Research Supply Index5.34 (2.92)
Research Growth Index4.90 (4.65)
Search Engine Demand Index95.25 (26.88)
Search Engine Supply Index2.01 (0.95)

This Compound (57.72)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews8 (3.85%)6.00%
Case Studies1 (0.48%)4.05%
Observational0 (0.00%)0.25%
Other199 (95.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]